Genome-scale DNA methylation analysis

Epigenomics

Volumn 2, Issue 1, 2010, Pages 105-117

  Fouse, Shaun D ^a   Nagarajan, Raman P ^a   Costello, Joseph F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA methylation; MeDIP; methylation sensitive restriction enzyme; microarray; MRE; next generation sequencing; reduced representation bisulfite sequencing; RRBS

Indexed keywords

BISULFITE; DNA;

ACCURACY; BASE PAIRING; CPG ISLAND; DNA DETERMINATION; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; GENE EXPRESSION; HUMAN; HUMAN GENOME; IMMUNOPRECIPITATION; MICROARRAY ANALYSIS; MICROCHIP ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BAYES THEOREM; CPG ISLANDS; DNA METHYLATION; DNA RESTRICTION ENZYMES; GENOME, HUMAN; HUMANS; IMMUNOPRECIPITATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 77954129622     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.09.35     Document Type: Review

References (80)

1. Trasler JM, Trasler DG, Bestor TH, Li E, Ghibu F: DNA methyltransferase in normal and Dnmtn/Dnmtn mouse embryos. Dev. Dyn. 206, 239-247 (1996).
2. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R: DNA hypomethylation leads to elevated mutation rates. Nature 395, 89-93 (1998).
3. Maraschio P, Zuffardi O, Dalla Fior T, Tiepolo L: Immunodefciency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. J. Med. Genet. 25, 173-180 (1988).
4. Xu GL, Bestor TH, Bourc'his D et al.: Chromosome instability and immunodefciency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402, 187-191 (1999).
5. Clark SJ, Harrison J, Frommer M: CpNpG methylation in mammalian cells. Nat. Genet. 10, 20-27 (1995).
6. Ramsahoye BH, Biniszkiewicz D, Lyko F et al.: Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl Acad. Sci. USA 97, 5237-5242 (2000).
7. Lister R, Pelizzola M, Dowen RH et al.: Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322 (2009).
8. Kriaucionis S, Heintz N: The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930 (2009).
9. Tahiliani M, Koh K P, Shen Y et al.: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
10. Rollins RA, Haghighi F, Edwards JR et al.: Large-scale structure of genomic methylation patterns. Genome Res. 16, 157-163 (2006).
11. Das R, Dimitrova N, Xuan Z et al.: Computational prediction of methylation status in human genomic sequences. Proc. Natl Acad. Sci. USA 103, 10713-10716 (2006).
12. Flanagan JM, Wild L: An epigenetic role for noncoding RNAs and intragenic DNA methylation. Genome Biol. 8, 307 (2007).
13. Rakyan VK, Blewitt ME, Druker R, Preis JI, Whitelaw E: Metastable epialleles in mammals. Trends Genet. 18, 348-351 (2002).
14. Waterland RA, Jirtle RL: Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 23, 5293-5300 (2003).
15. Hu M, Yao J, Cai L et al.: Distinct epigenetic changes in the stromal cells of breast cancers. Nat. Genet. 37, 899-905 (2005).
16. Bloushtain-Qimron N, Yao J, Snyder EL et al.: Cell type-specifc DNA methylation patterns in the human breast. Proc. Natl Acad. Sci. USA 105, 14076-14081 (2008).
17. Weber M, Davies JJ, Wittig D et al.: Chromosome-wide and promoter-specifc analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37, 853-862 (2005).
18. Rauch T, Li H, Wu X, Pfeifer GP: MIRA-assisted microarray ana lysis, a new technology for the determination of DNA methylation patterns, identifes frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res. 66, 7939-7947 (2006).
19. Rauch T, Wang Z, Zhang X et al.: Homeobox gene methylation in lung cancer studied by genome-wide ana lysis with a microarray-based methylated CpG island recovery assay. Proc. Natl Acad. Sci. USA 104, 5527-5532 (2007).
20. Rauch TA, Wu X, Zhong X, Riggs AD, Pfeifer GP: A human B cell methylome at 100-base pair resolution. Proc. Natl Acad. Sci. USA 106, 671-678 (2009).
21. Frommer M, McDonald LE, Millar DS et al.: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89, 1827-1831 (1992).
22. Pfeifer GP, Riggs AD: Genomic sequencing by ligation-mediated PCR. Mol. Biotechnol. 5, 281-288 (1996).
23. Clark SJ, Statham A, Stirzaker C, Molloy PL, Frommer M: DNA methylation: bisulphite modifcation and ana lysis. Nat. Protoc. 1, 2353-2364 (2006).
24. Gitan RS, Shi H, Chen CM, Yan PS, Huang TH: Methylation-specifc oligonucleotide microarray: a new potential for high-throughput methylation ana lysis. Genome Res. 12, 158-164 (2002).
25. Hatada I, Hayashizaki Y, Hirotsune S, Komatsubara H, Mukai T: A genomic scanning method for higher organisms using restriction sites as landmarks. Proc. Natl Acad. Sci. USA 88, 9523-9527 (1991).
26. Costello JF, Hong C, Plass C, Smiraglia DJ: Restriction landmark genomic scanning: ana lysis of CpG islands in genomes by 2D gel electrophoresis. Methods Mol. Biol. 507, 131-148 (2009).
27. Gonzalgo ML, Liang G, Spruck CH 3rd, Zingg JM, Rideout WM 3rd, Jones PA: Identifcation and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57, 594-599 (1997).
28. Huang TH, Laux DE, Hamlin BC, Tran P, Tran H, Lubahn DB: Identifcation of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fngerprinting technique. Cancer Res. 57, 1030-1034 (1997).
29. Toyota M, Ahuja N, Suzuki H et al.: Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59, 5438-5442 (1999).
30. Huang TH, Perry MR, Laux DE: Methylation profling of CpG islands in human breast cancer cells. Hum. Mol. Genet. 8, 459-470 (1999).
31. Bibikova M, Fan JB: GoldenGate assay for DNA methylation profling. Methods Mol. Biol. 507, 149-163 (2009).
32. Ladd-Acosta C, Pevsner J, Sabunciyan S et al.: DNA methylation signatures within the human brain. Am. J. Hum. Genet. 81, 1304-1315 (2007).
33. Ehrich M, Nelson MR, Stanssens P et al.: Quantitative high-throughput ana lysis of DNA methylation patterns by base-specifc cleavage and mass spectrometry. Proc. Natl Acad. Sci. USA 102, 15785-15790 (2005).
34. Raval A, Tanner SM, Byrd JC et al.: Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129, 879-890 (2007).
35. Yan PS, Chen CM, Shi H et al.: Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res. 61, 8375-8380 (2001).
36. Ching TT, Maunakea AK, Jun P et al.: Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specifc methylation of SHANK3. Nat. Genet. 37, 645-651 (2005).
37. Zhang X, Yazaki J, Sundaresan A et al.: Genome-wide high-resolution mapping and functional ana lysis of DNA methylation in Arabidopsis. Cell 126, 1189-1201 (2006).
38. Zilberman D, Gehring M, Tran RK, Ballinger T, Henikoff S: Genome-wide ana lysis of Arabidopsis Thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat. Genet. 39, 61-69 (2007).
39. Cross SH, Charlton JA, Nan X, Bird AP: Purifcation of CpG islands using a methylated DNA binding column. Nat. Genet. 6, 236-244 (1994).
40. Shen Y, Chow J, Wang Z, Fan G: Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Hum. Mol. Genet. 15, 2623-2635 (2006).
41. Shen Y, Matsuno Y, Fouse SD et al.: X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc. Natl Acad. Sci. USA 105, 4709-4714 (2008).
42. Fouse SD, Shen Y, Pellegrini M et al.: Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell 2, 160-169 (2008).
43. Weber M, Hellmann I, Stadler MB et al.: Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 39, 457-466 (2007).
44. Smith AE, Chronis C, Christodoulakis M et al.: Epigenetics of human T cells during the G0->G1 transition. Genome Res. 19, 1325-1337 (2009).
45. Liu CL, Schreiber SL, Bernstein BE: Development and validation of a T7 based linear amplifcation for genomic DNA. BMC Genomics 4, 19 (2003).
46. Hellman A, Chess A: Gene body-specifc methylation on the active X chromosome. Science 315, 1141-1143 (2007).
47. Yuan E, Haghighi F, White S et al.: A single nucleotide polymorphism chip-based method for combined genetic and epigenetic profling: validation in decitabine therapy and tumor/normal comparisons. Cancer Res. 66, 3443-3451 (2006).
48. Kerkel K, Spadola A, Yuan E et al.: Genomic surveys by methylation-sensitive SNP ana lysis identify sequence-dependent allele-specifc DNA methylation. Nat. Genet. 40, 904-908 (2008).
49. Bird AP, Taggart MH, Smith BA: Methylated and unmethylated DNA compartments in the sea urchin genome. Cell 17, 889-901 (1979).
50. Khulan B, Thompson RF, Ye K et al.: Comparative isoschizomer profling of cytosine methylation: the HELP assay. Genome Res. 16, 1046-1055 (2006).
51. Schumacher A, Kapranov P, Kaminsky Z et al.: Microarray-based DNA methylation profling: technology and applications. Nucleic Acids Res. 34, 528-542 (2006).
52. Oda M, Glass JL, Thompson RF et al.: High-resolution genome-wide cytosine methylation profling with simultaneous copy number ana lysis and optimization for limited cell numbers. Nucleic Acids Res. 37, 3829-3839 (2009).
53. Ball MP, Li JB, Gao Y et al.: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat. Biotechnol. 27, 361-368 (2009).
54. Brunner AL, Johnson DS, Kim SW et al.: Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res. 19, 1044-1056 (2009).
55. Lippman Z, Gendrel AV, Black M et al.: Role of transposable elements in heterochromatin and epigenetic control. Nature 430, 471-476 (2004).
56. Nouzova M, Holtan N, Oshiro MM et al.: Epigenomic changes during leukemia cell differentiation: ana lysis of histone acetylation and cytosine methylation using CpG island microarrays. J. Pharmacol. Exp. Ther. 311, 968-981 (2004).
57. Irizarry RA, Ladd-Acosta C, Carvalho B et al.: Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res. 18, 780-790 (2008).
58. Irizarry RA, Ladd-Acosta C, Wen B et al.: The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specifc CpG island shores. Nat. Genet. 41, 178-186 (2009).
59. Keshet I, Schlesinger Y, Farkash S et al.: Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet. 38, 149-153 (2006).
60. Pelizzola M, Koga Y, Urban AE et al.: MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. Genome Res. 18, 1652-1659 (2008).
61. Karpf AR, Peterson PW, Rawlins JT et al.: Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. Proc. Natl Acad. Sci. USA 96, 14007-14012 (1999).
62. Yamashita K, Upadhyay S, Osada M et al.: Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2, 485-495 (2002).
63. Foltz G, Yoon JG, Lee H et al.: DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array ana lysis. Oncogene 28(29), 2667-2677 (2009).
64. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21, 103-107 (1999).
65. Shames DS, Girard L, Gao B et al.: A genome-wide screen for promoter methylation in lung cancer identifes novel methylation markers for multiple malignancies. PLoS Med. 3, E486 (2006).
66. Gius D, Cui H, Bradbury CM et al.: Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell 6, 361-371 (2004).
67. Mueller W, Nutt CL, Ehrich M et al.: Downregulation of RUNX3 and TES by hypermethylation in glioblastoma. Oncogene 26, 583-593 (2007).
68. Morozova O, Marra MA: Applications of next-generation sequencing technologies in functional genomics. Genomics 92, 255-264 (2008).
69. Down TA, Rakyan VK, Turner DJ et al.: A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome ana lysis. Nat. Biotechnol. 26, 779-785 (2008).
70. Lister R, O'Malley RC, Tonti-Filippini J et al.: Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 133, 523-536 (2008).
71. Pomraning KR, Smith KM, Freitag M: Genome-wide high throughput ana lysis of DNA methylation in eukaryotes. Methods 47, 142-150 (2009).
72. Cokus SJ, Feng S, Zhang X et al.: Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 452, 215-219 (2008).
73. Meissner A, Gnirke A, Bell GW, Ramsahoye B, Lander ES, Jaenisch R: Reduced representation bisulfte sequencing for comparative high-resolution DNA methylation ana lysis. Nucleic Acids Res. 33, 5868-5877 (2005).
74. Meissner A, Mikkelsen TS, Gu H et al.: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766-770 (2008).
75. Smith ZD, Gu H, Bock C, Gnirke A, Meissner A: High-throughput bisulfte sequencing in mammalian genomes. Methods 48, 226-232 (2009).
76. Xi Y, Li W: BSMAP: whole genome bisulfte sequence MAPping program. BMC Bioinformatics 10, 232 (2009).
77. Clarke J, Wu HC, Jayasinghe L, Patel A, Reid S, Bayley H: Continuous base identifcation for single-molecule nanopore DNA sequencing. Nat. Nanotechnol. 4, 265-270 (2009).
78. Wyatt GR, Cohen SS: The bases of the nucleic acids of some bacterial and animal viruses: the occurrence of 5-hydroxymethylcytosine. Biochem. J. 55, 774-782 (1953).
79. Valinluck V, Sowers LC: Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 67, 946-950 (2007).
80. Rai K, Huggins IJ, James SR, Karpf AR, Jones DA, Cairns BR: DNA demethylation in zebrafsh involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 135, 1201-1212 (2008).